|
 |
|
|
Hematopoietic
|
| B-cell Clonality PCR |
| B-cell gene rearrangement |
| B-cell Ig Heavy Chain PCR |
| BCL1/IGH: t(11;14) PCR |
| BCL1 Major Translocation Cluster (MTC) analysis |
| BCL2 Major Breakpoint Region (MBR) |
| BCL2 Minor Cluster Region (MCR) analysis |
| BCR/ABL ALL Breakpoint (p190) |
| BCR/ABL CML Breakpoint (p210) |
| BCR/ABL: t(9;22) mRNA PCR, quantitative (p210) |
| BCR/ABL: t(9;22) mRNA PCR, qualitative (p210) (p190) |
| Bone Marrow Engraftment analysis, pre-transplant |
| Bone Marrow Engraftment analysis, post-transplant |
| Chimerism analysis, pre-transplant |
| Chimerism analysis, post-transplant |
| Follicular Lymphoma PCR |
| Gamma gene rearrangement |
| IGH/BCL2: t(14;18) PCR (mbr) (mcr) |
| Immunoglobulin gene rearrangement |
| J-Heavy Chain PCR (framework 1,2,3a) |
| JH gene rearrangement |
| Mantle Cell Lymphoma PCR |
| Philadelphia chromosome PCR, qualitative |
| Philadelphia chromosome PCR, quantitative |
| Short Tandem Repeat analysis, Pre-transplant |
| Short Tandem Repeat analysis, Post-transplant |
| STR Pre-transplant analysis |
| STR Post-transplant analysis |
| T-Cell Clonality PCR |
| T-Cell Receptor Gamma Chain PCR |
| T-Cell Receptor gene rearrangement |
| Translocation 9;22 PCR, qualitative |
| Translocation 9;22 PCR, quantitative |
| Translocation 11;14 PCR |
| Translocation 14;18 PCR |
|
Infectious
|
| Chlamydia |
| Chlamydia trachomatis |
| CMV PCR |
| C. trachomatis |
| CT |
| CT/NG Test for Chlamydia trachomatis, Neisseria gonorrrhoeae |
| Cytomegalovirus PCR |
| EBV PCR |
| Epstein Barr Virus PCR |
| Epstein Barr Virus, quantitative, for Lymphoproliferative Disease |
| GC |
| Gonnorrhoeae |
| HCV PCR, quantitative |
| Hepatitis C Virus PCR, quantitative |
| HHV-6 PCR |
| HHV-7 PCR, qualitative |
| HHV-8 PCR |
| KSHV PCR |
| Human Herpes Virus-6 PCR |
| Human Herpes Virus -7 PCR, qualitative |
| Human Herpes Virus-8 PCR, qualitative |
| Neisseria gonorrhoeae |
| N. gonorrhoeae |
| NG |
| Parvovirus B-19 PCR, qualitative |
| Varicella Zoster Virus PCR, qualitative |
| VZV PCR, qualitative |
|
Genetic
|
| Activated Protein C deficiency, Leiden type |
| Factor 2 (Prothrombin) mutation (20210G-A) |
| Factor II mutation analysis |
| F5 ARG506GLN, 1691G-A |
| F5 Leiden |
| Factor 5 Leiden mutation |
| Factor 5 Thrombophilia |
| Factor V Leiden mutation |
| Methyelenetetrahydrofolate Reductase DNA Variant analysis |
| MTHFR mutations (677C-T, 1298A-C) |
| MTHFR mutations (ALA222VAL, GLU429ALA) |
| MTHFR Thermolabile Polymorphisms |
| Prothrombin Variant analysis |
| Prothrombin Thrombophilia |
|
Solid Tumors
|
| Loss of Heterozygosity (LOH): 1p/19q fragment analysis |
| Oligodendroglioma PCR |
Last Modified: July 18, 2008 |
|
